Optimising Market Access for Rare Disease Products – NEW Market Access Guide now available

AscellaHealth is proud to launch a new strategic market access guide which will give industry stakeholders throughout EU/UK the best chance of bringing their rare or orphan disease products to market successfully.

Our experts have compiled a step-by-step guide to share insights on creating the perfect market access strategy - and why it’s so important to put one in place.

Within the guide, you’ll discover how to:

• Compile a market access strategy
• Build product value
• Develop a safety profile
• Identify the patient population size
• Determine pricing
• Contact external partners for support

AscellaHealth Executive Vice President & Managing Director, EU/UK, Craig Caceci, states, “We know how difficult it is to bring a rare disease product to market. With low patient prevalence, lack of understanding about these diseases and limited healthcare provider budgets, there is no guarantee that your product will make it to market.

“Companies are competing all the time for a range of products covering a large range of diseases. However, our new guide explains steps you can take to give yourself the best chance - especially when having a patient for the drug doesn’t necessarily guarantee that your product will enter the market and be paid for.”

Features include why a market access strategy is important and how to develop one effectively and early on in the cycle, how to build product value, as well as identifying patients who need treatment and barriers faced in accessing treatment.

Check it out now – guide available to download; click here.